Podcasts about chief medical officers

In this episode Dr. Simon Ruffell joins to discuss the research on ayahuasca for PTSD. Dr. Ruffell is a psychiatrist, researcher, and student of curanderismo (Amazonian shamanism) working at the intersection of Western psychiatry, traditional plant medicine, and Indigenous knowledge systems. He is Executive Director of Onaya, Lecturer in Psychology and Psychedelics at the University of Exeter, and Chief Medical Officer of MINDS, with a focus on integrative and relational approaches to healing and consciousness. In this conversation, Dr. Ruffell explores the emerging research on ayahuasca as a treatment for PTSD, drawing on both Western scientific models and Indigenous Shipibo knowledge systems. He outlines how ayahuasca may work through mechanisms such as increased neuroplasticity, disruption of rigid predictive models, and potential epigenetic shifts related to stress and trauma, while emphasizing that these biological explanations exist alongside Indigenous understandings of "cleaning ancestral lines." Sharing preliminary findings from his ongoing research with military veterans in collaboration with Heroic Hearts Project, Dr. Ruffell discusses significant reductions in PTSD symptoms at six-month follow-up, the powerful role of community and ceremony, and the ethical complexities of studying sacred practices through Western scientific tools. He closes with a moving story of a veteran whose healing journey illustrates both the promise and the limits of psychedelic medicine when embedded in relational and cultural context.   In this episode, you'll hear: Western scientific theories for how ayahuasca may alleviate PTSD How trauma-related epigenetic changes may be transmitted across generations Preliminary results from Dr. Ruffell's study of ayahuasca for veterans diagnosed with PTSD The role of community bonding and peer support among veterans in maintaining therapeutic gains Why ayahuasca research in the Amazon includes a broader plant-based healing system—not just the brew itself How Indigenous healers interpret epigenetic findings as confirmation of longstanding ancestral frameworks The ethical considerations of bringing Western measurement tools (like EEG) into sacred ceremonial contexts   Quotes: "This is what I find most interesting about our research—that it is cutting edge science but at the same time, when we conduct it with indigenous healers, we get a whole new perspective on what could be happening when it comes to interpreting the results and also making decisions of what to research as well." [14:09] "According to measures of PTSD on the scales that we're looking at, over 80% of the participants that were scoring for PTSD before their ayahuasca retreats and no longer scoring for PTSD at that six month follow up. So it's not just immediately after the ayahuasca retreats. It's six months later. And that's super, super encouraging." [15:52] "When we take things to the lab, one of the reasons that we might see the effect size diminishing is because we no longer have shamanism, basically, which is exerting a huge effect." [16:55] "Traditionally what would happen is that the curandero would drink ayahuasca and the participants would just be there and the curandero would use the visions that they had with ayahuasca to look into the participants and to diagnose them. And then the healing would come through them singing their medicinal chants, which are the icaros. And then afterwards they would give them a prescription of plants or whatever it is that they needed. And sometimes the prescription would be to drink ayahuasca, but most of the time it wouldn't be. [27:18] "You can't separate like DMT, in my eyes, from the rest of the compounds in ayahuasca, from the ceremony, from the jungle. That, in my opinion, is what makes up Shipibo. Otherwise you just have a bunch of chemicals." [28:20]   Links: Dr. Ruffell's website Dr. Ruffell on LinkedIn Dr. Ruffell on Instagram Onaya website Onaya Science website Onaya on LinkedIn Onaya on Instagram Previous episode: Can Ayahuasca Heal PTSD? with Former Army Ranger Jesse Gould Psychedelic Medicine Association Porangui

In this episode, we sit down with Dr. David Rabin for a mind-expanding conversation on what we've fundamentally gotten wrong about mental health—and why treating symptoms instead of root causes keeps us stuck. They unpack how smartphones hijack our dopamine, why modern convenience works against our nervous systems, and what it really takes to break free from a chronic sympathetic (fight-or-flight) state. From the ancestral role of dopamine and the science behind hugs to nuanced discussions on anxiety, autism spectrum disorder, psychedelics, and ibogaine, this episode bridges ancient biology with cutting-edge research. Dr. Rabin also dives into the “Ape Theory” and the importance of understanding specific mushroom strains rather than lumping them all together. The conversation wraps with insights on Apollo Neuro, sleep optimization, respiratory rates, the “first night effect,” and a refreshing reminder that living a simple, happy life may be the most powerful biohack of all.Dr. David Rabin, MD, PhD, is a translational neuroscientist, board-certified psychiatrist, health tech entrepreneur & inventor who has been studying the impact of chronic stress in humans for more than two decades. He is the co-founder & Chief Medical Officer at Apollo Neuroscience, which has developed the first scientifically-validated wearable technology that actively improves energy, focus & relaxation, using a novel touch therapy that signals safety to the brain.In addition to his clinical psychiatry practice, Dr. Rabin is currently conducting research on wearable and technology-based solutions for mental illnesses and the mechanism of psychedelic-assisted psychotherapy in treatment-resistant mental illnesses. He received his MD in medicine and PhD in neuroscience from Albany Medical College and specialized in psychiatry with a distinction in research at Western Psychiatric Institute & Clinic at the University of Pittsburgh Medical Center. He has been married to his co-founder, Kathryn Fantauzzi, since 2016.SHOW NOTES:0:40 Welcome to the podcast!4:06 About Dave Rabin5:03 Welcome him to the show!6:36 What have we gotten wrong about mental health?8:15 Interaction with our smart phones11:12 Treating symptoms, not the cause12:25 Breaking free from sympathetic state15:48 The ancestral purpose of dopamine19:06 Patience vs Convenience24:08 Why we need hugs for health28:29 *CALOCURB*29:40 Anxiety & Autism Spectrum Disorder 32:09 When are psychedelics appropriate?35:34 Knowing your mushroom strain39:42 Ibogaine benefits46:21 Germ theory & antibiotics51:12 The Ape Theory57:13 About the Apollo1:03:05 How it increases deep & REM sleep1:04:01 Average respiratory rates1:08:05 “First Night Effect”1:08:54 How to live a simple, happy life1:11:32 “The Four Agreements”1:15:03 His final piece of advice1:17:40 Thanks for tuning in!RESOURCES:Calocurb - code: RENEE10_______________Website: David Rabin MD, PhD, Apollo NeuroApollo Neuro - Discount code: BIOHACKERBABESDr. Rabin's Book: A Simple Guide to Being AliveInstagram: @drdavidrabinTwitter: @daverabinWikipedia: David Rabin MD, PhDPodcast Website: The Psychedelic NewsDocumentaries: How to Change Your Mind, War in WavesMycology Psychology FREE Community CallSupport this podcast at — https://redcircle.com/biohacker-babes-podcast/donationsAdvertising Inquiries: https://redcircle.com/brands

In this episode, Dr. Mayank K. Shah, Vice President and Chief Medical Officer of Advocate Condell Medical Center, part of Advocate Aurora Health, shares how his team elevated safety and quality to top Leapfrog grades, advanced AI adoption, and is building agility to navigate regulatory uncertainty and expand community focused care.

In this episode, Saria Saccocio, MD, MHA, Chief Medical Officer of Essence Healthcare, discusses the growing collaboration between payers and providers, the push for site neutral care and pharmacy cost reform, and the need for stronger investment in cardiometabolic and population health. She also shares how quality performance, member experience, and social determinants of health are shaping health plan strategy and margins heading into 2026.

In this episode of Talking Sleep, host Dr. Seema Khosla welcomes Dr. David McCarty, a sleep physician based in Colorado and Chief Medical Officer for REBIS HEALTH, to discuss the unique challenges of diagnosing and treating central sleep apnea at high altitude. Living and practicing sleep medicine in Colorado has given Dr. McCarty extensive experience managing altitude-related central sleep apnea, a condition that affects many residents and visitors to elevated regions. The conversation begins with fundamental questions: Is central sleep apnea normal at altitude? What physiological mechanisms drive its development? Dr. McCarty explains the prevalence patterns across different elevations, from Denver's mile-high altitude to extreme elevations like 10,000 feet, and whether there's a threshold where everyone develops central events. Practical diagnostic considerations receive detailed attention: Should patients be tested at their home altitude? How are titration studies conducted in high-altitude settings? What testing equipment best identifies central apneas, and should central hypopneas be scored? Dr. McCarty discusses the high prevalence of treatment-emergent central sleep apnea (TECSA) at altitude and how many patients present with mixed obstructive and central patterns, complicating treatment decisions. The episode provides essential guidance for clinicians whose patients travel to high altitude destinations. What PAP adjustments should be made? How should EPR (expiratory pressure relief) settings be modified? Dr. McCarty walks through his decision-making framework for when to treat altitude-related central apnea, emphasizing the importance of patient education before ascension. Treatment options are systematically reviewed: pressure adjustments, the role of BPAP therapy, when to consider ASV, acetazolamide use, and supplemental oxygen. Dr. McCarty discusses whether pre-emptive treatment is appropriate for patients planning high-altitude travel and provides practical protocols for managing both residents who live at altitude and visitors experiencing acute exposure. The conversation emphasizes patient-centered approaches, considering not just the physiological aspects of altitude-related breathing disturbances but also the practical realities of treating patients in mountain communities and preparing lowland residents for high-altitude adventures. Whether you practice in elevated regions, have patients who travel to altitude destinations, or simply want to understand the physiology behind altitude-related central sleep apnea, this episode provides essential clinical guidance. Join us for this informative discussion about a condition that affects millions living at or traveling to high elevations.

In this episode, Dr. Mayank K. Shah, Vice President and Chief Medical Officer of Advocate Condell Medical Center, part of Advocate Aurora Health, shares how his team elevated safety and quality to top Leapfrog grades, advanced AI adoption, and is building agility to navigate regulatory uncertainty and expand community focused care.

Dr. Charlotte McKee, Chief Medical Officer at Sionna, describes the nature of cystic fibrosis (CF, a genetic disease caused by a mutation in the single CFTR gene. While current CFTR modulator therapies do not address the most common mutation, Sionna's novel oral medicine is designed to target the previously undruggable NBDI domain of the CFTR protein. This new therapy aims to lead to better lung function and prevent the accumulation of permanent damage to other organs like the pancreas, gut, and liver.  Charlotte explains, "Cystic fibrosis is a genetic disease. The gene was actually discovered in 1989 for cystic fibrosis. It's considered a rare disease, but it's a relatively large rare disease. And one of those rare diseases that is potentially fatal, as you mentioned, it's thought of as a lung disease. And most patients, if their life is shortened, it's typically because of lung disease, because the lungs can be very severely affected. But the protein is caused by a genetic mutation in a gene called CFTR, and the protein is made from that gene. The CFTR protein is present on every epithelial cell of the body."   "Sionna is focused on a novel target in the CFTR protein. So you may know that, actually, there are approved medicines that have been developed over the last couple of decades that improve the function of the CFTR protein. And they've really advanced the clinical field, and there have been tremendous advances for people with CF. But this protein, this CFTR protein that goes wrong in CF, is a big, complicated, multi-part channel."   "Another unusual thing about CF is that there's one mutation that's so common around the world, and the part of CFTR that goes most wrong with F508del. This mutation is in a part of CFTR that was previously considered undruggable. It's that part that is called NBD1, and Sionna has been working for over a decade and a half of research, actually starting with Genzyme and then continuing through the company, Sanofi, has actually figured out how to develop potential medicines against this part of the CFTR protein that goes most wrong. And so we are working on these, they're called modulators, CFTR modulators, or we are working on NBD1-focused potential medicines that can directly bind to and stabilize this specific part of the CFTR protein."   #Sionna #CysticFibrosis #NBD1Stabilizers #CFTRModulators #RareDisease #Biotechnology #MedicalInnovation #PrecisionMedicine #GeneticDisease #PulmonaryHealth sionnatx.com Download the transcript here

Dr. Charlotte McKee, Chief Medical Officer at Sionna, describes the nature of cystic fibrosis (CF, a genetic disease caused by a mutation in the single CFTR gene. While current CFTR modulator therapies do not address the most common mutation, Sionna's novel oral medicine is designed to target the previously undruggable NBDI domain of the CFTR protein. This new therapy aims to lead to better lung function and prevent the accumulation of permanent damage to other organs like the pancreas, gut, and liver.  Charlotte explains, "Cystic fibrosis is a genetic disease. The gene was actually discovered in 1989 for cystic fibrosis. It's considered a rare disease, but it's a relatively large rare disease. And one of those rare diseases that is potentially fatal, as you mentioned, it's thought of as a lung disease. And most patients, if their life is shortened, it's typically because of lung disease, because the lungs can be very severely affected. But the protein is caused by a genetic mutation in a gene called CFTR, and the protein is made from that gene. The CFTR protein is present on every epithelial cell of the body."   "Sionna is focused on a novel target in the CFTR protein. So you may know that, actually, there are approved medicines that have been developed over the last couple of decades that improve the function of the CFTR protein. And they've really advanced the clinical field, and there have been tremendous advances for people with CF. But this protein, this CFTR protein that goes wrong in CF, is a big, complicated, multi-part channel."   "Another unusual thing about CF is that there's one mutation that's so common around the world, and the part of CFTR that goes most wrong with F508del. This mutation is in a part of CFTR that was previously considered undruggable. It's that part that is called NBD1, and Sionna has been working for over a decade and a half of research, actually starting with Genzyme and then continuing through the company, Sanofi, has actually figured out how to develop potential medicines against this part of the CFTR protein that goes most wrong. And so we are working on these, they're called modulators, CFTR modulators, or we are working on NBD1-focused potential medicines that can directly bind to and stabilize this specific part of the CFTR protein."   #Sionna #CysticFibrosis #NBD1Stabilizers #CFTRModulators #RareDisease #Biotechnology #MedicalInnovation #PrecisionMedicine #GeneticDisease #PulmonaryHealth sionnatx.com  Listen to the podcast here  

When employers look at all of the point solutions that are out there to add to their list of employee benefits, the top three should be… Primary care Primary care Primary care As a family medicine physician with an extensive background in advanced primary care, our guest today knows how true this is not just in theory, but in practice. Her work these days is getting employers to see the import of this investment as well. In her role as Chief Medical Officer, Dr. Marla McLaughlin partners directly with employers to identify workforce health priorities, design targeted strategies and apply real-time clinical insights to improve outcomes.  Dr. McLaughlin has dedicated her career to expanding access to high-quality primary care, guiding patients to the right care at the right time and fostering trusted patient-provider relationships. She believes the most effective healthcare combines technology with human-centric care to improve outcomes and experiences. McLaughlin brings that perspective and passion to Castlight Health and Vera Whole Health, where she plays a pivotal role in strengthening clinical operations, improving care quality and enhancing both patient and care team experiences.

(February 25, 2026) 1 int 10 Cal State students face homelessness… this emergency housing program helps. LAUSD shows big improvement in Advancement Placement class enrollment. Dr. Jim Keany, Chief Medical Officer at Dignity Health St. Mary Medical Center in Long Beach, joins The Bill Handel Show for 'Medical News'! Dr. Keany talks with Bill about nearsightedness having surged to near-epidemic levels, pulmonary embolisms, and early signs of heart attacks for women.See omnystudio.com/listener for privacy information.

In this episode, Douglas A. Ross, MD, CPE, FACS, Chief Medical Officer at AdventHealth Carrollwood, discusses rising pressures from age related neurological conditions, the shift toward team based and community anchored care models, and how biomarkers, functional imaging, and AI supported screening are reshaping early detection and treatment across the AdventHealth network.

A major measles outbreak is testing public health systems, community trust, and the power of vaccination. In this episode, Dr. Brannon Traxler, ASTHO member and Deputy Director of Health Promotion and Services & Chief Medical Officer, South Carolina Department of Public Health, shares the latest update on the state's response, with nearly 1,000 confirmed cases since October 2025. She explains why vaccination remains the cornerstone of outbreak control, how rapid case identification and contact tracing are helping to slow transmission, and what health officials are learning about spread within large, close-knit households.  Then, Heather Tomlinson, Senior Analyst of Environmental Health at the Association of State and Territorial Health Officials, breaks down the growing presence of kratom in U.S. markets. She explains its traditional use in Southeast Asia, how modern products differ from natural leaf preparations, and why highly concentrated or synthetic compounds are raising new health concerns. With federal guidance still evolving, states are developing a patchwork of policies—offering lessons for how public health can respond to emerging psychoactive substances.youtube.com/watch?v=cNt_Wgu8LqEKratom 101: What You Need to Know | ASTHOASTHO (@ASTHO) on XAssociation of State and Territorial Health Officials (@asthonews.bsky.social)Association of State and Territorial Health Officials (@asthonews) • Instagram profilehttps://www.linkedin.com/company/association-of-state-and-territorial-health-officials/ASTHO (Association of State and Territorial Health Officials)

If you're a woman in your late 30s, 40s, or 50s and you feel swollen, inflamed, stuck, exhausted, or like your body has completely turned against you — this series is for you. Let's be clear: This is NOT a diet episode. This is NOT food shaming. This is NOT about willpower. This is upstream endocrinology. In this episode, Dr. McCarthy explains: Why weight gain in perimenopause is not a discipline problem How estrogen dominance and low progesterone shift insulin sensitivity Why stress hormones (like cortisol) amplify fat storage How ultra-processed, hyper-palatable foods hijack your brain Why traditional diets (keto, low-fat, carnivore) often fail women The real role of insulin as a routing hormone — not just a blood sugar hormone Why GLP-1 medications can help — but shouldn't become “handcuffs” Most nutrition research was built on male physiology. You are not a small man. And it was never a fair fight.   Dr. Brendan McCarthy is the founder and Chief Medical Officer of Protea Medical Center in Arizona. With over two decades of experience, he's helped thousands of patients navigate hormonal imbalances using bioidentical HRT, nutrition, and root-cause medicine. He's also taught and mentored other physicians on integrative approaches to hormone therapy, weight loss, fertility, and more. If you're ready to take your health seriously, this podcast is a great place to start.  

Dr. Jim Keany, Chief Medical Officer at Dignity Health St. Mary Medical Center in Long Beach, joins The Bill Handel Show for 'Medical News'! Dr. Keany talks with Bill about nearsightedness having surged to near-epidemic levels, pulmonary embolisms, and early signs of heart attacks for women.See omnystudio.com/listener for privacy information.

In this episode, Douglas A. Ross, MD, CPE, FACS, Chief Medical Officer at AdventHealth Carrollwood, discusses rising pressures from age related neurological conditions, the shift toward team based and community anchored care models, and how biomarkers, functional imaging, and AI supported screening are reshaping early detection and treatment across the AdventHealth network.

In this episode, Matt Boles, MD, MHA, MSc, Chief Medical Officer at Salem Health Hospitals and Clinics, joins the podcast to reflect on the early stages of his executive journey in medicine. He discusses procedural capacity challenges, key priorities for 2026 including physician shortages, and areas for organizational growth, with a focus on the evolving role of the medical executive committee.

What does it really mean to own your fertility? In this episode, we're joined by Dr. Jaime Knopman from CCRM Fertility of New York and author of Own Your Fertility, for a candid conversation about egg freezing, fertility preservation, and grief. Dr. Knopman shares what inspired her to write the book, who it's for, and why fertility preservation can be one of the first acts of agency in reproductive health. We unpack common misconceptions about egg freezing. The conversation also turns to a topic often left unspoken: fertility-related grief. Dr. Knopman reflects on how grief shows up when timelines shift and how patients can hold both hope and loss at the same time. This episode is for anyone navigating fertility decisions, questioning timing, or seeking clarity and compassion along the journey. Own Your Fertility is now available on Amazon! Guest: Dr. Jaime Knopman, Board-Certified Reproductive Endocrinologist and Director of Fertility Preservation for CCRM Fertility of New York Hosts:  Dr. Janet Choi, Chief Medical Officer, Progyny Lissa Kline, LCSW, SVP, Provider and Member Services, Progyny --- For more information, visit Progyny's Education page. This show does not constitute medical advice. Be sure to follow us on Instagram, @progynyinc, and subscribe to our YouTube channel for more resources.   Music: YH1DOJKVSNXFR8GG (00:00) - Intro (01:58) - Why egg freezing and grief? (02:26) - Fertility preservation and egg freezing (05:06) - What is a good age to freeze eggs? (07:04) - If I freeze my eggs am I losing eggs? (08:55) - Egg freezing and birth control (09:30) - Breast cancer and fertility preservation (10:00) - Grief and family building (13:28) - The role of partners and community in family building (15:06) - Dr Knopman's Book! (16:12) - Fertility benefits create better outcomes (18:22) - Resilience (00:00) - Chapter 13 (00:00) - Chapter 14

Resources for the Community:___________________________________________________________________https://linktr.ee/theplussidezFind Your US Representatives https://www.usa.gov/elected-officials ______________________________________________________________________This isn't medical advice — always talk to your doctor before making any health decisions.Listener note: This episode includes candid discussion about sexual health and intimacy. Private listening is recommended if children are nearby.For many women in their late 30s, 40s, and 50s, treating metabolic dysfunction with a GLP-1 is only part of the story. Labs may improve. Weight may shift. But sleep changes. Mood feels different. Body composition moves in unfamiliar ways. Libido quietly declines.Perimenopause and menopause often unfold alongside metabolic treatment, and the hormonal transition can complicate everything.In this episode, we connect midlife hormone changes with metabolic health. Dr. Cathleen “Dr. Cat” Brown, board-certified OB/GYN and Medical Director at Winona, joins us along with Kelly Miller, Winona Patient Ambassador, to discuss what's happening during perimenopause and menopause, why hormone replacement therapy is back in the conversation, and what changed after the black box warning.We also speak candidly about sexual health in midlife, an area that rarely gets the honesty it deserves.For women navigating GLP-1 treatment or broader obesity care, this conversation widens the lens. Hormones matter. Context matters. And stigma around menopause deserves the same challenge as stigma around obesity.As always, this episode is for educational purposes only and is not medical advice.Get started with Winona https://start.bywinona.com/lp-menopause-care-with-winona?promocode=evergreen20&irclickid=yaKyxywNmxyKR9j1Qg0X3Rj3Uku2WWUNQXbEyw0&irgwc=1&afsrc=1&utm_Community Guest:Kelly Miller - Winona Patient AmbassadorProfessional Guest:Dr. Cathleen Brownfondly known as “Dr. Cat,” is a board-certified OB/GYN with over 12 years of service as an Army physician, where she gained deep experience caring for women's unique health needs. Today, she works as an OB laborist at Jefferson Abington Hospital near Philadelphia and serves as the Medical Director for Winona.In her role with Winona, Dr. Cat leads bi-monthly live Q&A sessions with Chief Medical Officer, Dr. Michael Green, answering questions about menopause symptoms and treatment and diving deep into related topicsSend us Fan Mail! Support the showKim Carlos, Executive Producer TikTok Instagram Kat Carter, Producer TikTok Instagram

After a decade in private practice, Dr. Claudia Emami transitioned from pediatric surgeon to Chief Medical Officer—driven by burnout and a deep curiosity about how healthcare systems function. In this episode, she shares the behind-the-scenes structure of hospital operations that every surgeon should know but rarely learns in training. We cover: The difference between medical staff and hospital administration Why bylaws are your protection How credentialing and peer review actually work Who sits in the C-suite—and what they control Why surgeons should proactively build relationships with their CMO and chief of staff How committee participation builds influence and opportunity Healthcare is becoming increasingly complex. Mergers, acquisitions, and system growth mean that physicians who don't understand governance risk losing their voice. This episode is a practical roadmap for surgeons who want to protect their autonomy, navigate hospital politics wisely, and possibly even explore leadership beyond the OR.

 In this episode, Neil Roy, MD, MBA, FACEP, CPE, Vice President of Diagnostic and Operative Services and Chief Medical Officer at Adventist HealthCare, shares how marketplace rounds, high risk discharge clinics, and remote monitoring cut length of stay by up to 15 percent and lowered readmissions below 10 percent, while strengthening physician engagement and preparing for AI driven patient flow innovation under Maryland's global budget model.

In this episode, Matt Boles, MD, MHA, MSc, Chief Medical Officer at Salem Health Hospitals and Clinics, joins the podcast to reflect on the early stages of his executive journey in medicine. He discusses procedural capacity challenges, key priorities for 2026 including physician shortages, and areas for organizational growth, with a focus on the evolving role of the medical executive committee.

In this episode, Ije Akunyili, MD, MBA, MPA, FACEP, Chief Medical Officer at Jersey City Medical Center, an RWJBarnabas Health facility, joins the podcast to discuss building a mortality and safety council, advancing women's health initiatives, and expanding partnerships to strengthen care delivery. She also shares how health systems can manage rising patient volumes while maintaining quality and safety.

The Non-Market Reality of Healthcare Carrier Marketplaces with Dr. Jacob Asher. In this episode of Relentlessly Seeking Value, host Stacey Richter introduces the 'No Market' series focused on the healthcare sector's lack of competitive market dynamics, which affects cost and quality.  The episode features a conversation with Dr. Jacob Asher, who has extensive experience as a Chief Medical Officer at major healthcare plans. They discuss the stagnant nature of commercial carrier marketplaces, particularly in California, and the various factors contributing to this stasis, including employer inertia, the influence of employee benefit consultants, and the strategic focus of carriers on Medicare Advantage over commercial business.  They also explore how carriers' dependence on existing provider networks and contractual negotiations based on member volumes contribute to a lack of meaningful competition. The episode highlights the challenges faced by plans attempting to innovate or differentiate on quality and the systemic issues that perpetuate the current equilibrium. === LINKS ===

Ever wanted to travel through time? Bet you didn't think you could do that in a podcast! In this special bonus episode of Not Just Fluff, host Hannah Shaw sits down with Dr. Alea Harrison, Chief Medical Officer at Banfield Pet Hospital, to celebrate seven decades of impact and explore the past, present, and future of pet care. Dr. Harrison shares her personal journey into veterinary medicine, her philosophy on leadership, and how innovation will shape the future of pet health. Whether you're a longtime pet owner or just beginning your journey, this conversation offers inspiration and a deeper understanding of how prevention truly creates a better world for the fluffy friends that give us so much! Follow us on social media!Facebook: Banfield Pet HospitalInstagram: @banfieldpethospitalDisclaimer: The information provided in this podcast is for informational purposes only and is not a substitute for professional veterinary advice. Always consult a veterinarian with any questions regarding your pet's health or medical condition. Never disregard or delay seeking professional veterinary advice based on information from this podcast.

 The Big Unlock · Dr. Andrea Willis, SVP & Chief Medical Officer, BlueCross BlueShield of Tennessee In this episode, Dr. Andrea Willis, SVP and Chief Medical Officer at BlueCross BlueShield of Tennessee, shares how payers can harness AI to advance affordable, accessible, and more human-centered care. From her clinical roots to leading population health, quality, and health equity initiatives, Dr. Willis brings a deeply personal commitment to service. She describes how AI is being deployed across care management and utilization management, not to replace clinicians or deny care, but to augment teams, accelerate evidence-based decisions, and close gaps in care. In care management, AI-powered summarization and prompting help staff stay fully present with members while improving engagement and measurable outcomes. In utilization management, transparency, evidence-based criteria, and clear documentation remain foundational to rebuilding provider trust. She also highlights that relevance matters more than data volume, and that guided self-service must balance automation with timely human escalation. Dr. Willis emphasizes transparency in prior authorization, cross-functional governance, AI literacy goals across the enterprise, and strong PHI protections. For here, scaling AI responsibly – through interoperability, collaboration, and measurable impact – is key to rebuilding trust and transforming the healthcare experience. Take a listen.

In this episode, host Sandy Vance chats with Dr. Sean Kelly, the Chief Medical Officer and the SVP of Customer Healthcare Strategy at Imprivata. Together, they unpack how healthcare organizations can strengthen cybersecurity without slowing clinicians down—exploring everything from mobile device security and passwordless authentication to adaptive authentication, risky user behaviors, and the very real implications for patient safety, workflow efficiency, and ROI for healthcare leaders.In this episode, they talk about:How cybersecurity can be improvedThe impact that Imprivata has on clinicians Why multi-factor authentication systems aren't more prevalent in the healthcare industryThe risky behaviors that open up organizations to security risksThe different things that Imprivata offers organizationsThe risks of patient harm in cybersecurity and privacyAdvice for CIOs or CFOs: workflow implications, security compliance, security and efficiency ROI, and financial valueAdaptive authentication at ImprivataA Little About Sean:Dr. Sean Kelly brings a uniquely well-rounded perspective to healthcare, shaped by a career that spans emergency medicine, healthcare leadership, technology, teaching, and entrepreneurship. An emergency physician at Beth Israel Lahey Health in Boston and an Assistant Clinical Professor of Emergency Medicine at Harvard Medical School, he is also the Chief Medical Officer and SVP of Customer Healthcare Strategy at Imprivata, where he helps guide product vision, go-to-market strategy, and customer experience after more than a decade with the company from startup through IPO and private equity ownership. He has led high-performing teams in both clinical and executive settings, contributed to care delivery improvements impacting millions of patients, published widely in emergency medicine and medical education, and earned multiple teaching awards. His background includes training at Harvard College, UMass Medical School, and Vanderbilt University, co-founding a concierge medical practice on Martha's Vineyard, international teaching and humanitarian work, and service in roles ranging from hospital administration to disaster relief—all grounded in a deep commitment to learning, mentorship, and collaboration.

In this episode, Ije Akunyili, MD, MBA, MPA, FACEP, Chief Medical Officer at Jersey City Medical Center, an RWJBarnabas Health facility, joins the podcast to discuss building a mortality and safety council, advancing women's health initiatives, and expanding partnerships to strengthen care delivery. She also shares how health systems can manage rising patient volumes while maintaining quality and safety.

In this episode, Peg Crowley-Nowick speaks with Joseph Elassal, MD, MBA, Chief Medical Officer of Ankyra Therapeutics, about the strategic, operational, and financial realities of leading clinical development from pre-IND through proof of concept and toward commercialization.   Drawing on experience across large pharma, biotech partnerships, and early-phase oncology, Joe shares a practical roadmap for new and aspiring CMOs. They discuss how to prioritize essential capabilities, including clinical operations, regulatory strategy, biostatistics, and pharmacovigilance, while determining the right time to introduce Medical Affairs. The conversation outlines how to scale teams at critical inflection points such as IND clearance, Phase 2 proof of concept, and advancement into Phase 3.   The episode also examines investor and board expectations, CRO selection, capital efficiency, cash runway management, and the performance metrics CMOs are ultimately judged on—from disciplined milestone execution to generating meaningful clinical data. This episode offers actionable insight for biotech founders, clinical development leaders, medical affairs professionals, and emerging CMOs navigating the path from early development to launch.

(February 18, 2026) Citing fire risk, L.A. city may get more power to remove hillside homeless encampments. Venezuela’s oil industry is in ruins… reviving it won’t be easy. Dr. Jim Keany, Chief Medical Officer at Dignity Health St. Mary Medical Center in Long Beach, joins The Bill Handel Show for 'Medical News'! Dr. Keany talks with Bill about intermittent fasting, sex drive and testosterone, AI stethoscopes, and Norovirus at the Winter Olympics. See omnystudio.com/listener for privacy information.

In this final episode of the Progesterone Promise series, Dr. Brendan McCarthy, Chief Medical Officer of Protea Medical Center, breaks down one of the most misunderstood hormones in women's health: progesterone. Progesterone is not “good” or “bad.” It's contextual. In today's world of quick sound bites and social media medicine, hormones are often reduced to oversimplified claims like “progesterone fixes anxiety” or “progesterone causes breast cancer.” The truth? It depends on your body, your stress levels, your liver health, your inflammation, your delivery method, and whether you're using bioidentical progesterone or synthetic progestins.   Citations: 1. Oral Progesterone → First-Pass Metabolism & Allopregnanolone Claim: Oral micronized progesterone undergoes significant hepatic first-pass metabolism, increasing neuroactive metabolites (especially allopregnanolone), which positively modulate GABA-A receptors and produce sedative/anxiolytic effects. Core Evidence: Simon et al., 1993; de Lignières et al., 1995; Freeman et al., 1990 — Oral progesterone produces measurable neuroactive metabolites. Paul & Purdy, 1992; Rupprecht et al., 2001 — Allopregnanolone enhances GABA-A receptor activity. Supports: Sedation variability by route • Neurosteroid generation • GABA-A modulation 2. Sulfation vs 5α-Reduction → Opposing Neurologic Effects Claim: Progesterone metabolites can produce calming (5α-reduced) or excitatory (sulfated) neurologic effects depending on enzyme routing. Core Evidence: Majewska et al., 1990 — Pregnenolone sulfate negatively modulates GABA-A. Wu et al., 1991 — Sulfated neurosteroids enhance NMDA signaling. Schumacher et al., 2007; Reddy, 2010 — Pathway reviews of sulfation vs 5α-reduction. Supports: Reverse responding hypothesis • Divergent neurologic experiences • Enzyme-dependent effects 3. Stress & Enzyme Modulation Claim: Chronic stress alters HPA axis tone and hepatic enzyme expression, influencing steroid metabolism balance. Core Evidence: McEwen, 1998 — Allostatic load model. Charmandari et al., 2005 — Cortisol's systemic regulatory effects. Zanger & Schwab, 2013; Gibson & Skett, 2001 — Stress alters cytochrome P450 expression. Supports: Stress-biased metabolism • Context-dependent hormone response 4. Breast Tissue Signaling & Context Claim: Progesterone influences mammary differentiation and interacts with estrogen signaling in context-dependent ways. Core Evidence: Brisken & O'Malley, 2010 — Progesterone receptor biology in breast tissue. Beleut et al., 2010 — RANKL mediates progesterone-driven proliferation. Hofseth et al., 1999 — PR-ER signaling interaction. Stanczyk & Bhavnani, 2014 — Natural vs synthetic differences in breast effects. Supports: Lobuloalveolar differentiation • RANKL pathway • Context-dependent proliferation 5. Synthetic Progestins vs Bioidentical Progesterone Claim: Synthetic progestins differ structurally and bind off-target receptors, producing distinct tissue effects. Core Evidence: Stanczyk et al., 2013 — Receptor binding differences. Sitruk-Ware, 2004 — Biologic comparisons. Chlebowski et al., 2003 (WHI) — Breast cancer signal with CEE + MPA. Supports: Structural divergence • Receptor-level differences • WHI clarification 6. Route of Delivery Differences Claim: Oral, vaginal, transdermal, and sublingual progesterone produce distinct pharmacokinetic profiles and tissue targeting. Core Evidence: Simon, 1995 — Oral vs vaginal PK comparison. Cicinelli et al., 2000 — “First uterine pass effect.” Wren et al., 2003 — Route-dependent systemic levels. Supports: Uterine targeting • Neurosteroid variability • Sedation differences 7. Progesterone, PMS & Migraine Claim: Neurosteroid fluctuations influence GABAergic tone and may contribute to PMS and migraine susceptibility. Core Evidence: Backstrom et al., 2011 — Allopregnanolone fluctuations in PMS. Reddy & Rogawski, 2002 — Neurosteroids and seizure threshold. Martin & Behbehani, 2001 — Hormonal fluctuations and migraine. Supports: Luteal neurosteroid shifts • GABA instability • Migraine association   Dr. Brendan McCarthy is the founder and Chief Medical Officer of Protea Medical Center in Arizona. With over two decades of experience, he's helped thousands of patients navigate hormonal imbalances using bioidentical HRT, nutrition, and root-cause medicine. He's also taught and mentored other physicians on integrative approaches to hormone therapy, weight loss, fertility, and more. If you're ready to take your health seriously, this podcast is a great place to start.  

Dr. Jim Keany, Chief Medical Officer at Dignity Health St. Mary Medical Center in Long Beach, joins The Bill Handel Show for 'Medical News'! Dr. Keany talks with Bill about intermittent fasting, sex drive and testosterone, AI stethoscopes, and Norovirus at the Winter Olympics. See omnystudio.com/listener for privacy information.

Dr. David Kirk, Chief Medical Officer at Regard, discusses the role and benefits of real-time clinical AI to help clinicians navigate patient charts and find critical information to prevent medication management errors and misdiagnoses. The Regard platform can also generate proactive documentation, allowing physicians to complete their documentation more accurately and efficiently, reducing note-bloat and the need for after-hours charting. One key goal of using AI is to free physicians to spend more time on the art of medicine, directly working with patients.   David explains, "So, Regard with real-time clinical artificial intelligence software, is helping clinicians propose the right diagnosis and information while they're working in the chart. Our mission is to make patient care as clear as possible. At the same time, we make sure that the doctors are getting the support they need so they can better support the patient. The charts of patients are getting bigger and bigger every year because more and more data is going into the charts. And as that happens, the really important thing that we as physicians need to find is diluted." "Some research even suggests that maybe doctors are going to see 3% of the data that comes in in the chart when a patient comes into the hospital. As the physician, I'm trying to understand a patient's clinical story with only having access to three pages. Our goal is for artificial intelligence to find important information in that deep sea of data so the treatment team can make better decisions. Maybe you can correct the documentation. What that means is the physician is doing all the work in their natural workflow. We're not having to do prep work during downtime at home, and we're not trying to wrap up notes at night. We need the documentation to be done proactively in a way that is as accurate as possible for the patient at the time of care." #Regard #HealthcareAI #DigitalHealth #MedicalTechnology #PatientCare #HealthTech #AIinMedicine #ClinicalDocumentation #HealthcareInnovation #MedicalAI #PhysicianSupport Regard.com Listen to the podcast here

Dr. David Kirk, Chief Medical Officer at Regard, discusses the role and benefits of real-time clinical AI to help clinicians navigate patient charts and find critical information to prevent medication management errors and misdiagnoses. The Regard platform can also generate proactive documentation, allowing physicians to complete their documentation more accurately and efficiently, reducing note-bloat and the need for after-hours charting. One key goal of using AI is to free physicians to spend more time on the art of medicine, directly working with patients.   David explains, "So, Regard with real-time clinical artificial intelligence software, is helping clinicians propose the right diagnosis and information while they're working in the chart. Our mission is to make patient care as clear as possible. At the same time, we make sure that the doctors are getting the support they need so they can better support the patient. The charts of patients are getting bigger and bigger every year because more and more data is going into the charts. And as that happens, the really important thing that we as physicians need to find is diluted." "Some research even suggests that maybe doctors are going to see 3% of the data that comes in in the chart when a patient comes into the hospital. As the physician, I'm trying to understand a patient's clinical story with only having access to three pages. Our goal is for artificial intelligence to find important information in that deep sea of data so the treatment team can make better decisions. Maybe you can correct the documentation. What that means is the physician is doing all the work in their natural workflow. We're not having to do prep work during downtime at home, and we're not trying to wrap up notes at night. We need the documentation to be done proactively in a way that is as accurate as possible for the patient at the time of care." #Regard #HealthcareAI #DigitalHealth #MedicalTechnology #PatientCare #HealthTech #AIinMedicine #ClinicalDocumentation #HealthcareInnovation #MedicalAI #PhysicianSupport Regard.com Download the transcript here

You can't delegate your longevity to a system that only gets paid when you're sick. In this episode of The Game Changing Attorney Podcast, Michael Mogill sits down with Dr. Bill Kapp, Chief Medical Officer and co-founder of Fountain Life, to explore the cutting edge of longevity science. Dr. Kapp reveals how creating a comprehensive digital twin with 250 gigabytes of personalized health data can detect fatal conditions 20 to 30 years before symptoms appear, why your family doctor is 17 to 20 years behind the latest technology, and how exponential innovations from gene editing to AI-powered diagnostics are reshaping what's possible for extending your healthspan. This conversation cuts through the influencer noise in the longevity space to focus on data-driven approaches backed by science, not hype. Here's what you'll learn: How full-body MRI scans with 10,000 slices and whole genome sequencing create a complete digital twin that enables personalized optimization Why muscle mass is the number one predictor of disease-free longevity and how lifting heavy outweighs everything else you can do Why you need to become the CEO of your own health and stop delegating your longevity to a broken medical system What you don't measure, you can't manage. It's time to become the CEO of your own health. ---- Show Notes: 02:39 – What Fountain Life is and the paradigm shift from symptom-based to proactive care. 12:13 – The comprehensive assessment: what gets measured and why it matters. 16:48 – The real risk of waiting and the airplane maintenance analogy. 20:01 – Genetics versus lifestyle: what's actually in your control. 26:01 – Making longevity technology accessible and what's coming next. 30:34 – Beyond detection: optimizing cellular health, hormones, and mitochondrial function. 41:29 – Longevity escape velocity and whether we can reverse aging in our lifetime. 44:06 – High-performance aging: why 80 doesn't have to mean slowing down. 45:45 – The top 3 takeaways: baseline testing, sleep optimization, and lifting heavy. ---- Links & Resources: Fountain Life Dr. Bill Kapp Tony Robbins Dr. Peter Diamandis Dr. Bob Hariri Why We Sleep by Dr. Matthew Walker ---- Do you love this podcast and want to see more game changing content? Subscribe to our YouTube channel. ---- Past guests on The Game Changing Attorney Podcast include David Goggins, John Morgan, Alex Hormozi, Randi McGinn, Kim Scott, Chris Voss, Kevin O'Leary, Laura Wasser, John Maxwell, Mark Lanier, Robert Greene, and many more. ---- If you enjoyed this episode, you may also like: 396. Why High Performers Can't Afford to Ignore Wellness with Dr. Taz Bhatia 283. Marcus Filly — Fitness Secrets for Professional Success 41. Dave Asprey —Becoming Bulletproof: Living Your Longest and Healthiest Life

Dr. Jeffrey Kopin, Chief Medical Officer, Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about Rev. Jesse Jackson being diagnosed with a rare neurological disorder, colorectal cancer now being the leading cause of cancer death in people under 50, and how concerned we should be about the rise in measles cases.

Dr. Kim Dennis brings a deeply integrative and courageous voice to the conversation on eating disorders, food addiction, trauma, and recovery. As a board-certified psychiatrist and the Co-Founder, CEO, and Chief Medical Officer of SunCloud Health (https://suncloudhealth.com/) she has spent more than two decades treating complex, co-occurring conditions—while also drawing from her own lived experience in long-term recovery from alcohol use disorder, bulimia, and food addiction. Dr. Dennis believes recovery must address the whole person: biological, psychological, social, and spiritual—not just symptoms or weight. A central theme of this episode is what happens when treatment doesn't work. Dr. Dennis points to a sobering reality: 30–50% of people with eating disorders do not respond to gold-standard treatments, often leaving patients believing they are broken. She challenges that narrative and argues that food addiction—particularly addiction to sugar and ultra-processed foods—is a critical and often dismissed missing piece. Drawing parallels to Big Tobacco, she explains how corporate influence, stigma, and lack of diagnostic legitimacy have delayed research funding, insurance coverage, and effective treatment, despite growing neurobiological evidence involving dopamine reward pathways, craving, withdrawal, and continued use despite harm. Dr. Dennis approaches every patient through a trauma-informed lens, emphasizing that all eating disorders and food addiction exist on a continuum shaped by disrupted safety, neglect, or adversity—what she describes as both “big T” and “little t” trauma. Rather than separating behavior from biology, she explains how trauma alters reward systems and coping mechanisms, making food a powerful regulator of emotion and survival. Her model centers on patient-led collaboration, clinical humility, and a strong therapeutic alliance—meeting people exactly where they are, without leaving them there. The conversation also explores some of the most debated issues in the field, including harm reduction versus abstinence, the eating-disorder community's resistance to food addiction, and the expanding use of GLP-1 medications. Dr. Dennis stresses that abstinence is a “tricky word” that must be defined clinically and individually—not ideologically—and that medications may have a place when used thoughtfully, transparently, and alongside comprehensive care. She closes with a message of hope: recovery is not about weight or perfection, lives do get bigger, and no one should stop seeking answers simply because one approach failed.      #eatingdisorderrecovery  #healthyliving  #obesity  #MAHA    Dr. Nicole Avena (https://www.instagram.com/drnicoleavena/?hl=en) #ashleygearhardt #foodaddiction #ultraprocessed #addictionscience  #foodfreedom

Dr. Jeffrey Kopin, Chief Medical Officer, Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about Rev. Jesse Jackson being diagnosed with a rare neurological disorder, colorectal cancer now being the leading cause of cancer death in people under 50, and how concerned we should be about the rise in measles cases.

Dr. Jim Adams, Chief Medical Officer of Northwestern Medicine, joins Wendy Snyder, filling in for Lisa Dent, to discuss several health topics. He shares some information about colorectal cancer and its warning signs, whether or not people who have gotten the measles vaccine need a booster, and some lifestyles changes people can make to help reduce their […]

Dr. Jeffrey Kopin, Chief Medical Officer, Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about Rev. Jesse Jackson being diagnosed with a rare neurological disorder, colorectal cancer now being the leading cause of cancer death in people under 50, and how concerned we should be about the rise in measles cases.

Dr. Frank Peacock and Dr. Damon R. Kuehl join BioTalk for a focused discussion on one of emergency medicine's most persistent challenges: accurately diagnosing and predicting outcomes in mild traumatic brain injury. As Scientific Advisory Board members for BrainBox Solutions, Inc., they walk through what happens when a patient presents to the emergency department after a fall or sports injury and why current tools, including CT scans, often leave clinicians without clear answers. The conversation explores the gap between a "normal" scan and ongoing symptoms, and what missed or uncertain diagnoses can mean for patients weeks later.   Dr. Peacock outlines the HeadSMART II study and explains why combining blood biomarkers with neurocognitive testing provides a more complete assessment than biology alone. Dr. Kuehl discusses how multi-modal data, integrated through artificial intelligence, can generate an objective score to support real-time clinical decision-making and help identify patients at risk for persistent symptoms. The episode also highlights BrainBox's leadership, including CEO Donna Edmonds, a member of the BioHealth Innovation Board of Directors, and the company's role in advancing objective mTBI testing.   Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com).   Dr. W. Frank Peacock IV is Professor of Emergency Medicine at Baylor College of Medicine. Chief Medical Officer at AseptiScope, and the founder of both a contract research organization called Comprehensive Research Associates, LLC and a medical education company named Emergencies in Medicine, LLC. Dr. Peacock received his medical degree from Wayne State University Medical School and completed his Emergency Medicine training at William Beaumont Hospital. He has >900 peer reviewed publications and is also the co-editor of multiple medical textbooks on heart failure, acute coronary syndromes, and traumatic brain injury.   Dr. Damon R. Kuehl is the Vice Chair of Research and Academic Affairs and Professor in the Department of Emergency Medicine at Virginia Tech, School of Medicine. He completed Medical School at University of Minnesota Medical School and his Emergency Medicine Residency at Stanford University. He has also completed residencies in Preventive Medicine and a Research Fellowship in the Center for Policy and Research in Emergency Medicine, at Oregon Health and Science University. Dr. Kuehl's research primarily focuses on diagnostic and prognostic uncertainty in brain injury. He is a lead investigator for HeadSMART II and for HeadSMART Geriatrics, a NINDS funded 3 year study to develop a diagnostic tool for head trauma in older adults.  He is the founder of the Carilion Brain Injury Center and also an investigator with the Virginia Tech Center for Biomechanics studying the boundary conditions associated with injuries in older adult falls.

Dennis P.H. Mihale, MD MBA CHCQM, is an ER physician, healthcare executive and chief medical officer who has been delivering care for over 35 years. He currently serves as Chief Medical Officer at Upward Health and is an Assistant Professor at University of South Florida Medical School. Prior to joining Upward Health, he served as the Chief Medical Officer of Consolidated Health Plan, where he was responsible for developing the medical management strategy and creating a Patient Centered Medical Home strategy. He has also served as the CMS Physician Champion for ICD-10 in Florida, founded and led two managed care companies and has served as Chief Medical Officer or Medical Director to more than 15 companies. Denniss biomedical and healthcare technology experience includes working with the IBM Watson Center, NASAs Technology Transfer Team, SMRxT and PatientKeeper. He serves on the advisory boards for Datacys and Revasurrant, and other healthcare technology companies. Dennis received a B.S. in Aerospace Engineering from SUNY Buffalo, an M.D. from the University of Miami School of Medicine and an M.B.A. from the University of South Florida. He retired as a Major from the US Army Reserve MC. His awards include CEO of the Year: Tampa Bay Forum; Entrepreneur of the Year: USF College of Business Administration; Physician Business Leader of the Year: Medical Business Journal and is a Fellow of the National Science Foundation.See omnystudio.com/listener for privacy information.

Dennis P.H. Mihale, MD MBA CHCQM, is an ER physician, healthcare executive and chief medical officer who has been delivering care for over 35 years. He currently serves as Chief Medical Officer at Upward Health and is an Assistant Professor at University of South Florida Medical School. Prior to joining Upward Health, he served as the Chief Medical Officer of Consolidated Health Plan, where he was responsible for developing the medical management strategy and creating a Patient Centered Medical Home strategy. He has also served as the CMS Physician Champion for ICD-10 in Florida, founded and led two managed care companies and has served as Chief Medical Officer or Medical Director to more than 15 companies. Denniss biomedical and healthcare technology experience includes working with the IBM Watson Center, NASAs Technology Transfer Team, SMRxT and PatientKeeper. He serves on the advisory boards for Datacys and Revasurrant, and other healthcare technology companies. Dennis received a B.S. in Aerospace Engineering from SUNY Buffalo, an M.D. from the University of Miami School of Medicine and an M.B.A. from the University of South Florida. He retired as a Major from the US Army Reserve MC. His awards include CEO of the Year: Tampa Bay Forum; Entrepreneur of the Year: USF College of Business Administration; Physician Business Leader of the Year: Medical Business Journal and is a Fellow of the National Science Foundation.See omnystudio.com/listener for privacy information.

Chief Medical Officer at Central DuPage Hospital Dr. Tom Moran joins Bob Sirott to discuss the importance of screening for colorectal cancer and why doctors aren’t agreeing when it comes to diagnosing Alzheimer’s. He also talks about healthy heart habits, foods than can help lower blood pressure, and how your brain functions when you don’t […]

In this episode, Thomas Graf, MD, Chief Medical Officer for Florida Blue, part of GuideWell, shares how the health plan is improving cancer care through a high-touch, tech-enabled navigation program for Medicare Advantage members. He discusses reducing variation, closing gaps between diagnosis and treatment, and achieving better outcomes, higher satisfaction, and lower costs by centering care around the patient experience.

Sometimes, I see a book and think, "Did the author just decide to write that especially for me???"  Okay, I know Heather Tabers didn't write Books & Battlefields just for me, but listen in and learn why she did--and a lot more! note: links may be affiliate links that provide me with a small commission at no extra expense to you.  Loved chatting with Heather about this book, particularly since it's WWI set in the US!  That doesn't happen often. Also, I loved that she wrote the sort of "love triangle" that actually makes sense.  I also loved seeing how the Victory Book Campaigns could've been sparked by those that happened in WWI! Books & Battlefields  by Heather Tabers A spirited librarian with a guarded heart. A haunted surgeon battling the past. A quiet deputy who never stopped hoping. Isabella Pearson isn't looking for love—only a way to serve. In 1917, she leaves her privileged Denver life behind to volunteer as a librarian at Camp Sheridan, Alabama. With a suitcase full of books and a heart determined to remain independent, she never expects to find herself being pursued by two men: Nathaniel, her brother's steadfast best friend, and Byron, the brooding Chief Medical Officer who makes her pulse race for all the wrong reasons. Major Byron McDaniel has buried his heart with his late wife and plans to keep it that way. Yet Isabella's courage and compassion rattle the walls he's so carefully built. Meanwhile, Nathaniel Steele has followed Isabella to Alabama with hopes of finally winning the heart he's long treasured in silence. But as tensions rise at Camp Sheridan—with a suspicious fire, a string of accidents, and whispers of sabotage—Isabella must navigate more than just her feelings. When loyalty, love, and liberty hang in the balance, will she trust her heart—or her instincts?  Learn more about Heather on her WEBSITE and follow on GoodReads and BookBub. Like to listen on the go? You can find Because Fiction Podcast at: Apple Castbox Google Play Libsyn RSS Spotify Amazon and more!

Join Our Medical Device Sales Program: https://click.newtomedicaldevicesales.com/yt-431If you're new to my channel, my name is Jacob McLaughlin. I'm the founder of New to Medical Device Sales, an exclusive training program designed to help people break into the competitive field of medical device sales. Our average person lands a six-figure role in just 9.5 weeks, earning $113,760 annually. With thousands of success stories from candidates with all kinds of backgrounds, our program equips you with the tools to succeed in this industry.4 years ago I moved out to Arizona not knowing anyone and had $1200 to my name.I came to this exact spot to journal and share how excited I was to be starting my journey in life.Last night I took time to reflect over the past 4 years. It's truly amazing how you can change your life in such a small amount of time.My take aways:1. Go after your dream because even if it doesn't workout like you thought it would, it will bring your right where you're suppose to be.2. Believe in yourself. Nobody is going to believe in you as much as you will, know that good things will happen.3. Change is inevitable. Change is going to happen so you can either accept it and keep moving forward or not.Please bet on yourself and go after your dreams because your life can be better than you ever thought it could be if you do

Behind every public health response are two make-or-break factors: the people doing the work and the systems that help them work together.  First, Shirley Orr, Executive Director of the Association of Public Health Nurses discusses the Public Health Nursing Workforce Learning Lab Series Session 5 with insights from PHWINS, the nation's only survey of the state and local public health workforce, which reached nearly 50,000 professionals. The data paints a detailed picture of who makes up today's workforce, including an influx of younger staff, persistent leadership diversity gaps, and ongoing concerns about burnout and morale. Later, Dr. Lisa Villarroel, Chief Medical Officer for Public Health of the Arizona Department of Health Services shows us what happens when that workforce is connected in real time. Arizona's Statewide Healthcare Collaborative Forum, a simple monthly virtual call during respiratory season, brings EMS, hospitals, post-acute care, and public health leaders together to review virus trends, hospital capacity, ED diversion, and emerging challenges. Born from pandemic lessons, the forum has led to tangible results: resolving EMS transport delays, sparking regional hospital alliances, rethinking masking policies, and aligning state data with frontline reality.Meeting Home PageMeeting Home Page

In this episode, Dr. Sidney H. Raymond, Chief Medical Officer at Ochsner Health Network, discusses leading population health across more than 600,000 lives and advancing value based care beyond contract boundaries. He shares how care model redesign, prevention focused strategies, digital health, and patient centered culture are driving measurable gains in quality, cost, and care coordination across diverse communities.

Medicare for all. Not socialized medicine, just a single, government-run system that provides healthcare.  Is it possible? Or even viable? Our guest this week on the Creating a New Healthcare podcast believes so. In fact, he sees it as the only way to ultimately address the affordability problem with healthcare, particularly for high cost conditions like cancer. In today's episode, we talk with Dr. Troy Brennan about his book, The Transformation of American Health Insurance: On the Path to Medicare for All, and why a single payer, government system is needed, and how the changes the current administration has made to our public health systems is taking us backwards, not forward. Troyen Brennan is an Adjunct Professor at Harvard Chan School of Public Health.  He was formerly the Executive Vice President and Chief Medical Officer for CVS Health and Aetna. Before that, he was the President of the Brigham and Women's Physician Organization and Professor of Medicine at Harvard Medical School.  He was also Professor of Law and Public Health at the Harvard Chan School of Public Health.  Brennan was formerly the Chair of the American Board of Internal Medicine and is a member of the National Academy of Medicine. He has published six books and over 600 articles. 

(February 11, 2026) Nancy Guthrie: Video released, person detained and released. Los Angeles and Long Beach among the least affordable cities in the world. Dr. Jim Keany, Chief Medical Officer at Dignity Health St. Mary Medical Center in Long Beach, joins The Bill Handel Show for 'Medical News'! Dr. Keany joins the show from Milan, Italy and the Winter Olympics where his AirBnB had… BED BUGS!See omnystudio.com/listener for privacy information.